THALIDOMIDE TREATMENT PREVENTS CHRONIC GRAFT REJECTION AFTER AORTIC TRANSPLANTATION IN RATS

BACKGROUND: Cardiac allograft vasculopathy (CAV) affects approximately 30% of cardiac transplant patients at five years post-transplantation. To date there are few CAV treatment or prevention options, none of which are highly effective. The aim of the study was to investigate the effect of thalidomi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transpl Int
Main Authors: Miller, Katharine K., Wang, Dong, Hu, Xiaomeng, Hua, Xiaoqin, Deuse, Tobias, Neofytou, Evgenios, Renne, Thomas, Velden, Joachim, Reichenspurner, Hermann, Schrepfer, Sonja, Bernstein, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643223/
https://ncbi.nlm.nih.gov/pubmed/28672061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tri.13004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados